Omaveloxolone similarly decreased tumor size (Figure 5A,B) and weight (Figure 5C) by 85.4% and 70.7%, respectively, limiting tumor growth to approximately 200 mm3 after 10 days of treatment in KEAP1 KO tumors. The gene discussed is KEAP1; the disease is neoplasm.